815 followers
Development of an engineered peptide antagonist against periostin to overcome doxorubicin resistance in breast cancer. https://t.co/SnrmN0ZtYz https://t.co/5ntUXLJnzF
Development of an engineered peptide antagonist against periostin to overcome doxorubicin resistance in breast cancer. https://t.co/SnrmN0ZtYz https://t.co/5ntUXLJnzF